In this study, we analyzed mTNFα expression regulation both at the transcriptional and post-translational levels to demonstrate for the first-time high expression and activity of TACE/ADAM-17 in IFN-DCs from glioblastoma patients. Here, ADAM17 is linked to glioblastoma.